AVADEL PHARMACEUTICALS PLC (AVDL) Net Cash Provided by (Used in) Financing Activities USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Avadel Pharmaceuticals Plc quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2024.
  • Avadel Pharmaceuticals Plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $13.2M, a 61.7% decline year-over-year.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.2M -$21.3M -61.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $135M +$121M +831% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q1 2023 $34.4M +$32.4M +1614% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $14.5M +$14.3M +5430% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q1 2022 $2.01M +$1.86M +1248% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $263K -$179M -99.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q1 2021 $149K -$62.1M -99.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $180M +$180M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q1 2020 $62.2M +$62.1M +67520% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$27K -$113M -100% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
Q1 2019 $92K -$123M -99.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $113M +$136M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q1 2018 $123M +$123M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$23.3M -$15.4M -193% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q1 2017 -$406K +$6.57M +94.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$7.95M +$15.8M +66.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q1 2016 -$6.98M -$6.9M -8734% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$23.8M -$120M -125% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q1 2015 -$79K -$80.2M -100% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $96M +$77.7M +425% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-28
Q1 2014 $80.1M +$65.8M +459% Jan 1, 2014 Mar 31, 2014 6-K 2014-07-08
Q4 2013 $18.3M +$11.3M +163% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q1 2013 $14.3M +$13.6M +1833% Jan 1, 2013 Mar 31, 2013 6-K 2014-07-08
Q4 2012 $6.96M +$810K +13.2% Jan 1, 2012 Dec 31, 2012 20-F/A 2015-10-01
Q1 2012 $741K +$2.58M Jan 1, 2012 Mar 31, 2012 6-K 2012-09-13
Q4 2011 $6.15M +$6.92M Jan 1, 2011 Dec 31, 2011 20-F/A 2014-04-30
Q1 2011 -$1.84M Jan 1, 2011 Mar 31, 2011 6-K 2012-09-13
Q4 2010 -$774K Jan 1, 2010 Dec 31, 2010 20-F 2013-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.